Michael A. Metzger
2017
In 2017, Michael A. Metzger earned a total compensation of $1.2M as Chief Operating Officer at Syndax Pharmaceuticals, a 67% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $182,900 |
|---|---|
| Option Awards | $546,228 |
| Salary | $491,625 |
| Other | $3,000 |
| Total | $1,223,753 |
Metzger received $546.2K in option awards, accounting for 45% of the total pay in 2017.
Metzger also received $182.9K in non-equity incentive plan, $491.6K in salary and $3K in other compensation.
Rankings
In 2017, Michael A. Metzger's compensation ranked 8,008th out of 14,666 executives tracked by ExecPay. In other words, Metzger earned more than 45.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,008 out of 14,666 | 45th |
Division Manufacturing | 3,007 out of 5,768 | 48th |
Major group Chemicals And Allied Products | 984 out of 2,074 | 53rd |
Industry group Drugs | 769 out of 1,730 | 56th |
Industry Pharmaceutical Preparations | 606 out of 1,329 | 54th |
Source: SEC filing on April 10, 2018.
Metzger's colleagues
We found two more compensation records of executives who worked with Michael A. Metzger at Syndax Pharmaceuticals in 2017.
News
Syndax Pharmaceuticals CEO Briggs Morrison's 2021 pay jumps 80% to $3.9M
March 29, 2022
Syndax Pharmaceuticals CFO Daphne Karydas receives $3.1M in 2020
April 1, 2021
Syndax Pharmaceuticals COO Michael Metzger's 2019 pay jumps 77% to $2.7M
April 29, 2020
Syndax Pharmaceuticals CEO Briggs Morrison's 2018 pay jumps 24% to $2.1M
April 30, 2019